rs545740473
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001292063.2(OTOG):c.4627G>A(p.Ala1543Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000593 in 1,528,824 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.4627G>A | p.Ala1543Thr | missense_variant | 36/56 | ENST00000399397.6 | NP_001278992.1 | |
OTOG | NM_001277269.2 | c.4663G>A | p.Ala1555Thr | missense_variant | 35/55 | NP_001264198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.4627G>A | p.Ala1543Thr | missense_variant | 36/56 | 5 | NM_001292063.2 | ENSP00000382329 | P2 | |
OTOG | ENST00000399391.7 | c.4663G>A | p.Ala1555Thr | missense_variant | 35/55 | 5 | ENSP00000382323 | A2 | ||
OTOG | ENST00000342528.2 | n.1965G>A | non_coding_transcript_exon_variant | 12/22 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00316 AC: 479AN: 151772Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.000666 AC: 88AN: 132102Hom.: 0 AF XY: 0.000659 AC XY: 46AN XY: 69828
GnomAD4 exome AF: 0.000306 AC: 422AN: 1376934Hom.: 1 Cov.: 31 AF XY: 0.000262 AC XY: 177AN XY: 676020
GnomAD4 genome AF: 0.00319 AC: 484AN: 151890Hom.: 4 Cov.: 32 AF XY: 0.00306 AC XY: 227AN XY: 74246
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 17, 2020 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | p.Ala1555Thr in exon 35 of OTOG: This variant is not expected to have clinical s ignificance due to a lack of conservation in mammals. Of note, three mammals (sq uirrel, manatee, Cape golden mole) have a threonine (Thr) at this position. It h as been identified in 0.6% (5/774) of African chromosomes by the Exome Aggregati on Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs545740473). - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 23, 2018 | - - |
OTOG-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 02, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at